Arcadia Biosciences, Inc. (RKDA) - Q2 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2024. Arcadia Biosciences, Inc. is a producer and marketer of innovative, plant-based products, focusing on wheat traits and coconut water (Zola brand). The company is classified as a non-accelerated filer and a smaller reporting company. As of August 6, 2024, there were 1,362,840 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | YTD 2024 (6 Months) | Q2 2023 (3 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Total Revenues | $1.31 million | $2.29 million | $1.30 million | $2.38 million |
| Net Income (Loss) | $1.06 million | $(1.36) million | $0.82 million | $(8.57) million |
| Net Income (Loss) from Continuing Ops | $1.85 million | $0.90 million | $3.16 million | $(4.24) million |
| Net Loss from Discontinued Ops | $(0.79) million | $(2.27) million | $(2.34) million | $(4.33) million |
| Cash and Cash Equivalents | $5.50 million (as of June 30, 2024) | |||
| Short-term Investments | $2.60 million (as of June 30, 2024) | |||
| Working Capital | $9.74 million (as of June 30, 2024) | |||
| Accumulated Deficit | $(273.20) million (as of June 30, 2024) |
Material Changes and Unusual Items
- Asset Sales and Gains: The company recorded a $4.0 million gain on the sale of its non-GMO Resistant Starch (RS) durum wheat trait to Corteva AgriScience. This was a non-recurring item that significantly impacted net income.
- Discontinued Operations: The GoodWheat brand was sold to Above Food Corp. in May 2024. Operations for GoodWheat and the Body Care division (Soul Spring, ProVault) are reported as discontinued operations. GoodWheat generated a net loss of $0.79 million in Q2 2024.
- Receivables: A $6.0 million promissory note was received from Above Food Corp. in connection with the GoodWheat sale, with $1.76 million classified as current and $3.97 million as non-current.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased by 29% in Q2 2024 compared to Q2 2023, primarily due to legal and consulting fees related to the Corteva and Above Food transactions.
- Valuation Changes: The change in fair value of common stock warrant and option liabilities resulted in a loss of $0.43 million in Q2 2024, compared to a gain of $4.42 million in Q2 2023.
Guidance, Outlook, and Risks
- Going Concern Warning: Management has raised substantial doubt about the company's ability to continue as a going concern. They believe existing cash ($5.5 million), short-term investments ($2.6 million), and the current note receivable ($1.8 million) will not be sufficient to meet anticipated cash requirements for the next 12-18 months.
- Capital Needs: The company may need to raise additional funds through debt or equity financings, which could result in dilution or debt service obligations. Failure to secure funding could force spending reductions or asset liquidation.
- Strategic Focus: The company plans to scale the Zola coconut water brand through retail expansion and continue to monetize its wheat trait portfolio. They are also evaluating M&A opportunities.
- Risks: Key risks include regulatory uncertainty in the CBD market (leading to the exit of body care brands), reliance on third-party partners for commercialization, and the need for additional capital.
Investor Verification Checklist
- Verify the sustainability of the $4.0 million gain from the Corteva trait sale and its impact on future earnings.
- Assess the collectability and terms of the $6.0 million promissory note from Above Food Corp.
- Review the company's specific plans and timeline for raising additional capital to address the going concern warning.
- Monitor the performance and revenue growth of the Zola coconut water brand as the primary remaining product line.
- Check for any updates on the valuation of liability-classified warrants and options, which caused significant volatility in prior periods.